Floatz logo

128 assets in Stroke Disorder

Therapeutic assets addressing Stroke Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Human Relaxin 1
Stroke Disorder
Deeptankar DeMazumderP1/2CC (41)
Infliximab
Stroke Disorder
University of California, San FranciscoP1/2CC (41)
Mtr-601
Stroke Disorder
Motric BioP1CC (40)
Alloex
Stroke Disorder
The Foundation for Orthopaedics and Regenerative MedicineP1C (37)
N,N-Dimethyltryptamine
Stroke Disorder
Algernon PharmaceuticalsP1C (37)
Teonanacatl
Stroke Disorder
Johns Hopkins UniversityP1C (37)
Alirocumab
Stroke Disorder
The First Affiliated Hospital with Nanjing Medical UniversityEarly P1C (34)
Carbon Dioxide
Stroke Disorder
Imperial College LondonN/AD (30)
Edoxaban [Lixiana]
Stroke Disorder
Humanis Saglık Anonim SirketiN/AD (30)
K-13675, (R)-
Stroke Disorder
Tokyo Women's Medical UniversityN/AD (30)
Oxygen
Stroke Disorder
Capital Medical UniversityN/AD (30)
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER
Stroke Disorder
University Hospital, BordeauxN/AD (28)
Bont A
Stroke Disorder
Kayseri City HospitalN/AD (28)
Bont Injections
Stroke Disorder
Vastra Gotaland RegionN/AD (28)
Dextrose
Stroke Disorder
Istanbul Physical Medicine Rehabilitation Training and Research HospitalN/AD (28)
Exenatide
Stroke Disorder
Rigshospitalet, DenmarkN/AD (28)
Midodrine
Stroke Disorder
Singapore General HospitalN/AD (28)
Noradrenaline
Stroke Disorder
Zhejiang Cancer HospitalN/AD (28)
Normal Human Serum Albumin
Stroke Disorder
Rigshospitalet, DenmarkN/AD (28)
Salvianolic Acid
Stroke Disorder
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (28)
Sarpogrelate
Stroke Disorder
Ewha Womans University Seoul HospitalN/AD (28)
Sodium Chloride
Stroke Disorder
Peking Union Medical College HospitalN/AD (28)
Ulinastatin
Stroke Disorder
Beijing Tiantan HospitalN/AD (28)
Zoledronate
Stroke Disorder
University of IoanninaN/AD (28)
Showing 101 to 128 of 128 assets
PreviousPage 3 of 3Next